Merrill; Jean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merrill; Jean.The latest application filed is for "1, 3, 4-oxadiazol-2-ones as ppar delta modulators and their use thereof".

Company Profile

0.6.14

Merrill; Jean - Morristown NJ
Merrill; Jean - Whippany NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof Grant 7,872,032 - McGarry , et al. January 18, 2	2011-01-18
Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists Grant 7,709,509 - Keil , et al. May 4, 2	2010-05-04
1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease Grant 7,638,539 - McGarry , et al. December 29, 2	2009-12-29
1, 3, 4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof App 20090275621 - MCGARRY; Daniel G. ; et al.	2009-11-05
1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof Grant 7,576,109 - McGarry , et al. August 18, 2	2009-08-18
Coumarins as iNOS inhibitors Grant 7,538,233 - Jackson , et al. May 26, 2	2009-05-26
Methods For The Treatment Of Metabolic And Glucose Utilization Disorders Through The Administration Of Oxadiazolones And Derivatives Thereof As Peroxisome Proliferator - Activated Receptor (ppar) Delta Agonists App 20080262052 - KEIL; Stefanie ; et al.	2008-10-23
Oxadiazolones And Derivatives Thereof As Peroxisome Proliferator - Activated Receptor (ppar) Delta Agonists App 20080255212 - KEIL; Stefanie ; et al.	2008-10-16
Methods Of Treating Demyelinating Disorders App 20070280885 - Chandross; Karen ; et al.	2007-12-06
Use Of Certain Phenyl Napthyl Compounds For Protection Of Neurons And Oligodendrocytes In The Treatment Of Multiple Sclerosis (ms) App 20070249732 - MERRILL; Jean ; et al.	2007-10-25
Use Of Certain Biphenyl Compounds For Protection Of Neurons And Oligodendrocytes In The Treatment Of Multiple Sclerosis (ms) App 20070249706 - MERRILL; Jean ; et al.	2007-10-25
Oxadiazolones And Derivatives Thereof As Ppar Delta Agonists App 20070179191 - KEIL; Stefanie ; et al.	2007-08-02
Use Of Peroxisome Proliferator Activated Receptor Delta Agonists For The Treatment Of Ms And Other Demyelinating Diseases App 20070149580 - CHANDROSS; Karen ; et al.	2007-06-28
Secreted neural apoptosis inhibiting proteins App 20070128667 - Merrill; Jean ; et al.	2007-06-07
1, 3, 4-oxadiazol-2-ones As Peroxisome-proliferator Activated Receptor Delta Modulators And Their Use In The Treatment Of Neurological And Metabolic Disease App 20070099964 - McGarry; Daniel G. ; et al.	2007-05-03
1,3,4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof App 20070060626 - MCGARRY; Daniel G. ; et al.	2007-03-15
Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders Grant 7,132,428 - Majid , et al. November 7, 2	2006-11-07
Coumarins as iNOS inhibitors App 20050054681 - Jackson, Sharon ; et al.	2005-03-10
Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders App 20050009859 - Majid, Tahir Nadeem ; et al.	2005-01-13
Osteopontin, oligodendrocytes and myelination App 20040033226 - Merrill, Jean ; et al.	2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.